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Mini Abstract. 
Risk factors of surgical site infection and positive effect of prostaglandin E1 in patients 
with spinal metastasis were evaluated.   Diabetes and preoperative irradiation were the 
independent risk factors by multivariate analysis.   Prostaglandin E1 administration 
was found to decrease the rate of surgical site infection in patients with preoperative 
irradiation. 
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Study Design.  A retrospective review (Phase 1) and prospective clinical study (Phase 
2) 
Objectives.  The objectives of this study were to identify independent risk factors for 
surgical site infection (SSI) and to evaluate the positive effect of prostaglandin E1 
(PGE1) to decrease the risk of SSI in patients with spinal metastasis. 
Summary of Background Data.  Surgery for spinal metastasis is associated with an 
increased risk of SSI. Although previous reports have evaluated risk factors of SSI for 
spinal metastasis, most of the studies lack multivariate analysis. A recent study 
demonstrated the utility of PGE1 in decreasing wound complications in patients with 
prior irradiation. The role of PGE1 in surgery for spinal metastasis has not been 
previously evaluated. 
Methods.  110 patients with spinal metastasis were retrospectively reviewed (phase 1). 
Risk factors for SSI were analyzed using logistic regression.  Phase 2 was a 
prospective clinical trial investigating the utility of PGE1 at reducing the rate of SSI. 94 
patients for with spinal metastasis were treated at our institute. The infection rate and 
risk factors identified in phase 1 and 2 were compared.  
Results.  The rate of SSI during Phase 1 was 7.1%. Independent risk factors identified 
by multivariate logistic regression were diabetes, and preoperative irradiation. The rate 
of SSI for patients who had irradiation before surgery was 32%, while the rate for 
patients without irradiation was 1.1%. This difference was statistically significant. The 
rate of SSI in Phase 2 was 3.1%. In Phase 2 patients who received preoperative 
irradiation, the rate of SSI was 4.5%. The difference between Phase 1 and Phase 2 was 
statistically significant. 
Conclusions: This study identified diabetes and preoperative irradiation to be 
independent risk factors for SSI in patients with spinal metastasis.   PGE1 
administration was found to significantly decrease the incidence of SSI in patients with 
spinal metastasis who underwent preoperative irradiation. 
 
Introduction 
The purposes of surgical treatment for spinal metastasis are to avoid recurrence of 
the tumor, and to control spinal paralysis to maintain the patient's quality of life until the 
last moment.   On the other hand, patients with spinal metastasis might have poor 
nutritional status and be prone to immunosupression from disease or treatments.   
Hence, the surgery for spinal metastasis is still controversial because it has potential 
risks of postoperative systemic complications.   Recent literatures have reported 
excellent functional outcomes after the surgery for spinal metastasis with falling 
morbidity rates12, 13, although, the rate of complication remains relatively high 
compared to other spinal surgeries.   Wise et al11 reported that the rate of complication 
was 25%.   In all these reports, a major cause of morbidity was surgical site infection 
(SSI).    
SSI is one of the serious complications and may compromise the quality of outcome.   
A variety of risk factors for SSI in spinal surgery have been reported.   Patient 
characteristics reported to increase the risk of SSI following spinal surgery are advanced 
age, preoperative malnutrition, presence of diabetes, preoperative or perioperative 
steroid therapy, and preoperative adjunctive therapy including chemotherapy or 
irradiation at the surgical site.   Surgery-related risk factors reported to be associated 
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with increase risk of SSI are increased duration of surgery, increased blood loss, repeat 
spinal surgery at the surgical site, posterior instrumentation surgery, and procedure of 
the tumor resection.1-5   For the surgery in spinal metastases, the rate of SSI is reported 
from 12 to 20%5-7, higher than other spinal surgeries.   Although previous reports have 
evaluated risk factors of SSI for spinal metastasis, most of the studies lack multivariate 
analysis.   Furthermore, a recent study demonstrated the utility of prostaglandin E1 
(PGE1) in decreasing SSI after laryngeal surgery in patients with prior irradiation.   
The role of PGE1 in surgery for spinal metastasis has not been previously evaluated.   
So, there were two phases to this study, Phase 1 was to identify independent risk factors 
of SSI and Phase 2 was to evaluate the positive effect of PGE1 to decrease the risk of 
SSI in patients with spinal metastasis.    
 
Phase 1 Study  
Material and Methods 
110 patients (113 surgeries) with spinal metastasis, treated between 1993 January 
and 2003 March, were retrospectively reviewed.   There were 45 women and 65 men, 
with a median age 56.0 years (range 32-72 years).   The main lesion was located in the 
thoracic spine in 58 patients, in the lumbar spine in 40, and in the cervical spine in 12.   
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The primary tumors were cancer of the kidney (22), breast (17), lung (14), colon (11), 
thyroid (10), prostate (5), liver (4), unknown (5), and others (22).   According to the 
surgical strategy for spinal metastases by Tomita et al8, an appropriate oncologic 
surgical procedure was selected for each patient based on the prognostic score, which is 
obtained by summing points of the three prognostic factors.   Wide or marginal 
excision such as total en bloc spondylectomy was performed in 38 patients (two-staged 
surgeries were performed in 3 patients).   Debulking surgery such as piecemeal 
excision or eggshell curettage was performed in 43 patients.   Palliative surgery such 
as spinal cord decompression with spinal stabilization was performed in 29 patients. 
(Table 1)   The mean prognostic score was 3.7 points in patients treated by wide or 
marginal excision, 5.1 points in patients treated by debulking surgery, and 6.4 points in 
patients treated by palliative surgery.  
Perioperative patient characteristics and surgery-related characteristics reported to 
be risk factors for SSI in previous studies4,5, 9 were evaluated in this study.   All of the 
patients in this study received prophylactic antibiotics (Cephem antibiotic agent was 
given in 94 patients, Penicillin antibiotic agent in 8 patients, and other prophylactic 
antibiotics in 11 patients).   To detect a difference between the incidence of SSI and 
risk factors, univariate methods were used.   Contingency tables were used to assess 
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association by Fisher’s exact test.   A P value less than 0.05 was considered 
statistically significant.   For multivariate analysis, multivariate stepwise logistic 
regression was used to identify independent risk factors for SSI.   The variables with 
univariate P values less than 0.2 were considered as candidates for multiple logistic 
regression.   Statistical analyses was performed using SPSS 11.0 software (SPSS Inc., 
Chicago, IL).    
 
Results 
In the period of this study, the incidence of SSI was 7.1% (8/113 surgeries).   
Microrganisms isolated from these wounds were coagulase-negative Staphylococcus in 
3 cases, Staphylococcus aureus in 2 cases, Escherichia coli in 1 case, Candida albicans 
in 1 case, and Pseudomonas aeruginosa in 1 case. (Table 2)   All cases were classified 
as deep SSI, and five of the 8 patients underwent repeated surgery because of their SSI.   
The results of the univariate analyses of risk factors are shown in Table 3 and 4.   The 
median age of the patients was 56.0 years.   Age >56 was not a statistically significant 
risk factor by univariate analysis (odds ratio [OR] 0.58, 95% confidence interval [CI] 
0.13-2.54, P = 0.71).   Gender was not a significant risk factor (male OR 1.16, 95% CI 
0.26-5.15, P = 0.84).   All the diabetic patients were type I and were treated with oral 
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therapy.   The presence of diabetes was a significant risk factor (OR 17.7, 95% CI 
3.64-43.6, P < 0.01).   In this study, a serum albumin less than 3.5 g/dL was defined to 
be malnutrition.10   Malnutrition was not a significant risk factor (OR 2.21, 95% CI 
0.39-12.5, P = 0.37).   American Society of Anesthesiologists class (ASA) indicates 
the extent of illness.   ASA of 3 or 4 was not a statistically significant risk factor (OR 
1.72, 95% CI 0.87-3.40, P = 0.11).   In this study, 37 of 110 patients received 
chemotherapy as treatment of the primary tumor.   The history of chemotherapy was 
not a statistically significant risk factor (OR 3.80, 95% CI 0.85-16.9, P = 0.08).   Prior 
irradiation at surgical site was performed in 22 patients.   The rate of SSI with 
irradiation was 31.8% (7 of 22 cases), much higher than those without irradiation (1.1%, 
1 of 91 cases).   This difference was statistically significant (OR 41.0, 95% CI 
4.82-63.6, P < 0.01).   Administration of perioperative steroids was performed in 67 
patients who had paraparesis due to spinal cord compression.   The use of steroids was 
not a significant risk factor (OR 2.06, 95% CI 0.40-10.7, P = 0.39).   74 patients had 
neurologic deficit due to spinal cord compression.   The presence of neurologic deficit 
did not affect SSI (OR 3.96, 95% CI 0.47-33.5, P = 0.21).   In phase 1 study, total en 
bloc spondylectomy was performed in 38 patients (41 surgeries), debulking surgery in 
43 patients, and palliative surgery in 29 patients.   Two (4.8%) of 41 surgeries 
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developed SSI following en bloc spondylectomy, compared with two (4.7%) of 43 
surgeries following debulking surgery, and four (13%) of 29 surgeries following 
palliative surgery.   There was no association between type of the surgery and SSI 
(Table 4).   The history of multiple operation at surgical site affected SSI by univariate 
analysis (OR 1.85, 95% CI 1.11-3.05, P = 0.02).   Emergency surgery was performed 
in 17 patients due to acute paraparesis.   The emergency surgery was not a statistically 
significant (OR 0.92, 95% CI 0.45-1.90, P = 0.83).   Prolonged operation time and 
high blood loss were reported to be risk factors for SSI in spinal surgery2.   However, 
most of the surgery for spinal metastasis was long duration (median 315min), and high 
blood loss (median 1560ml).   Neither the operation time (OR 0.83, 95% CI 0.60-1.16, 
P = 0.29) nor blood loss (OR 0.52, 95% CI 0.56-1.51, P = 0.39) were statistically 
significant in surgery for spinal metastasis.   In this study, both univariate and 
multivariate analyses were used to evaluate potencial risk factors.   Stepwise 
regression analysis included the three significant factors (P < 0.05) and two factors 
which were relatively large, with P values of less than 0.2 by univariate analysis.   
These five factors were diabetes, prior irradiation, multiple operations at the surgical 
site, preoperative chemotherapy, and ASA class.   Only diabetes and irradiation at 
surgical site were the independent risk factors significantly by multivariate logistic 
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regression.   Multiple operations at the surgical site with statistical significance by 
univariate but not by multivariate analyses did not have a direct relation, but might 
serve as markers of increased risk (Table 5). 
   Diabetes was an independent risk factor for SSI in spinal metastasis (OR 17.1, P = 
0.011).   The infection rate of the patients with diabetes was 35.7% (5 of 14 cases).   
The rate of the patient without diabetes was 3.0% (3 of 99 cases), which was 
significantly different (P<0.01).   A prior irradiation at surgical site was also 
independent risk factor for SSI in spinal metastasis (OR 19.5, p = 0.016).   The rate of 
SSI with irradiation was 31.8% (7 of 22 cases), much higher than those without 
irradiation (1.1%, 1 of 91 cases).    
 
Phase 2 Study 
Material and Methods 
The second portion of the study (Phase 2) was a prospective clinical trial 
investigating the utility of PGE1 at reducing the rate of SSI in patients treated with 
preoperative irradiation.   Phase 2 occurred between April 2003 and December 2007, 
during which time 94 patients (97 surgeries) with spinal metastasis were treated at our 
institute.  There were 41 women and 53 men, with a mean age 57.7 years (range 29-82 
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years).   The main lesion was in the thoracic spine in 68 patients, in the lumbar spine 
in 20, and in the cervical spine in 6.   Wide or marginal excision such as total en bloc 
spondylectomy was performed in 50 patients (two-staged surgeries were performed in 3 
patients).   Debulking surgery such as piecemeal excision or eggshell curettage was 
performed in 27 patients.   Palliative surgery such as spinal cord decompression with 
spinal stabilization was performed in 17 patients.   All the patients with prior 
irradiation at surgical site received intravenous PGE1 administration at 60 μg twice daily 
after the surgery, for mean duration 7 days.   The infection rate and risk factors 
identified in Phase 1 and Phase 2 were compared.    
 
Results 
The incidence of SSI was 3.1% (3/97 surgeries).   Microrganisms isolated from 
these wounds were Staphylococcus aureus (methicillin resistant) in 2 cases, 
Enterococcus faecalis in 1 case.   All cases were classified as deep SSI, and they all 
underwent repeated surgery.   The rate of SSI between Phase 1 and Phase 2 were not 
significantly different (p = 0.23, Fisher’s exact test).   When the patients who had 
prior irradiation were compared, there were no significant difference between Phase 1 
and Phase 2 in age, gender, operation time, blood loss amount, total dose of irradiation 
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before surgery, and interval between irradiation and operation. (Table 6)   On the other 
hand, the rate of SSI for patients who had prior irradiation in phase 2 was 4.5% (1/22 
cases), the difference between phase 1 and 2 was statistically significant. (p = 0.046, 
Fisher’s exact test) (Table 7). 
 
Discussion 
   Several risk factors for infection after the surgery for spinal metastasis have been 
identified.   Bridwell et al6 reported that wound dehiscence in 3 (12%) of 25 patients 
who had undergone posterior instrumentation with posterolateral decompression and 
debulking for spinal metastasis.   McPhee et al5 found that SSI occurred 15 (20%) of 
75 cases after the surgery.   Preoperative protein depletion and perioperative steroid 
administration were risk factors for SSI by univariate analysis.   Sundaresan et al7 
identified that wound breakdown and infection occurred in 11 (14%) of 80 cases who 
underwent surgery for spinal metastasis.   Major risk factors for the surgery of spinal 
metastases was age over 65 years, paraparesis, and the prior use of radiation, 
chemotherapy, or both.   In this study, diabetes, prior irradiation, multiple operation at 
surgical site were associated with a higher incidence of surgical site infection by 
univariate analysis.   However, risk factors by univariate but not multivariate analysis 
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might not have a direct relation to SSI.   In this study, independent risk factors 
identified by multivariate logistic regression were diabetes, and preoperative irradiation. 
The increased risk of SSI in patients with diabetes after spinal surgery is well 
reported2, 17, 18.   Multi-factorial reasons, such as ischemia due to impaired granulocyte 
adherence20 and microangiopathy19, have been documented.   Olsen et al reported that 
diabetes, and a preoperative serum glucose level of > 125 mg/dL or a postoperative 
glucose level of > 200 mg/dL were the independent risk factors by multivariate 
analysis21.   Therefore, more aggressive intravenous control of serum glucose level 
might reduce the incidence of SSI in spinal surgery.   In cardiac surgery, it is recently 
reported that insulin-delivery pumps have been shown to be effective in reducing the 
risk of SSI 22.   Additional study will be needed to confirm the efficacy of continuous 
intravenous insulin infusion in patients with diabetes for spinal surgery.   On the other 
hand, the positive effect of PGE1 in reducing the incidence of infection has not been 
shown.   PGE1 is one of a potent vasodilator that will increase peripheral blood flow.   
Therefore, there is a possibility that PGE1 administration might decrease the incidence 
of SSI in patients with diabetes.    Further investigation will be needed whether PGE1 
administration might decreases the incidence of SSI in patients with diabetes.    
The relationship between poor nutritional status and SSI has been reported.   Klein et 
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al. found that preoperative nutritional status defined by serum albumin level was a 
significant risk factor for infectious complications in patients with elective lumbar 
surgery1.   Contrary, Blam et al reported that depressed preoperative serum albumin 
was not statistically associated with wound infections in patients with spinal injury27.   
In this study, malnutrition defined by serum albumin was not statistically significant.   
However, we could not determine whether the patients with low albumin were 
associated with increased risk of SSI for spinal metastases because of the small number 
in this study population.   A higher statistical power might be needed to disprove that 
other negative factors in this study are not at work.
Irradiation has multiple negative influences on wound repair, including decreased 
vascularity with fibrosis, hypoxia, and impairment of proliferative capacities of local 
tissues, which are responsible for the remodeling of collagen in surgical wounds14.   
Experimental study demonstrated that irradiated tissue cannot tolerate bacterial 
contamination resulting in an incidence of SSI16.   Ghogawalla et al15 reported that the 
rate of wound complication was 32% in patients who received prior irradiation, which 
was three times higher than in patients without irradiation.   Sunderesan et al also 
reported that the rate of wound breakdown was 25% (10 out of 40 patients) in patients 
who received prior irradiation.   In this study, the rate of SSI with irradiation was 
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31.8% (7 of 22 cases), much higher than those without irradiation (1.1%, 1 of 91 cases).   
Our result that preoperative irradiation increased the rate of SSI has been substantiated 
by the results in other studies.   Wise et al11 indicated that a decision should be made 
before radiation therapy about whether conservative or operative treatment will be 
pursued because the preoperative irradiation raised the rate of SSI. 
On the other hands, a recent study demonstrated the positive effect of PGE1 in 
decreasing wound complications after laryngeal surgery in patients with preoperative 
irradiation23.   PGE1 is a potent vasodilator that will increase peripheral blood flow.   
Clinically, PGE1 has been found useful for ischemia in patients with peripheral arterial 
occlusive disease24, performing free flap salvage25, and so on.   The positive effects of 
PGE1 on increasing skin and muscle blood flow have been shown in a dog model26.   
The role of PGE1 in spine surgery has not been previously evaluated.   So, we 
performed a prospective clinical trial to investigate the utility of PGE1 in patients with 
prior irradiation.   In this study, PGE1 administration was found to significantly 
decrease the incidence of SSI in patients with spinal metastasis who underwent 
preoperative irradiation.   By PGE1 usage, possible side effects are generally pain at 
the injection site, headache, mild decrease of blood pressure, and hemorrhagic tendency.   
However, side effects by PGE1 administration should be reduced in doses below 0.01 
 12
micrograms/kg/min.   Furthermore, monitoring is not generally required.   In this 
series, PGE1 was administered below 0.01 micrograms/kg/min in all cases, and 3 cases 
of pain at the injection site were seen.   Although small patient numbers limits the 
significance of the current study, the positive effect of PGE1 in patients with spinal 




We investigated risk factors of surgical site infection and evaluated the positive effect of 
prostaglandin E1 administration in patients with spinal metastasis. 
Independent risk factors by multivariate logistic regression were diabetes and 
preoperative irradiation. 
Prostaglandin E1 administration was found to decrease the incidence of surgical site 
infection in patients with spinal metastasis who underwent preoperative irradiation. 
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Characteristics of 110 patients 




















Median age (range) 56 (32-72)
Gender (male : female) 65:45




















Organism No. of cases


































Univariate Analysis of Patient Characteristics























* American Society of Anesthesiologists class 
The P values were calculated with Fisher exact test, and significant values (<0.05) 
Are listed in bold type.
Table 4.
Univariate Analysis of Surgery-related Risk Factors














































Adjusted Odds Ratio 










Stepwise logistic regression selected two risk factors with significantly
independent association with surgical site infection. 
Significant P values (< 0.05) are listed in bold type.
Table 6.









•Total dose of radiation (Gy)
•Interval between radiation 
and operation (months) 
P value
58.4 ± 8.3 54.1 ± 11.1
11 / 11 9 / 13
295 ± 171 400 ± 183
1310 ±945 1104 ±585
44.1 ± 10.5 39.9 ± 12.3







Values are given as mean ± standard deviation.   NS = not significant.   The P 










21 (95.5) 1 (4.5)
15 (68.2) 7 (31.8)
P = 0.04, with Fisher exact test
